Latest on Clinical Research
Latest on Preclinical Research, AI in Healthcare and everything else!
Subscribe to the Newsletter
PLEASE: check your SPAM folder from time to time. Newsletters tend to be classified as spam 🙁
Want to stay in the loop without the hassle of hunting down updates? Subscribe to my newsletter! You’ll get the latest blog posts delivered straight to your inbox, no digging required. There’s no set schedule for my updates (life is a little unpredictable!), but I aim to share something new with you at least once a week!
If you want to read the past newsletters, please click here or on Newsletters in the main menu.
Donations
I am now accepting financial contributions to help support two key efforts. First, I’ll soon need to cover the cost of the newsletter delivery system (Kit.com). Second, I’m eager to continue developing the Navigator Project—an intuitive tool designed to simplify prostate cancer trial research by filtering results based on a range of parameters. It will be fast, user-friendly, and straightforward (at least, that’s the goal!).
You will be redirected to https://prostatewarriors.kit.com/products/jar
Emerging Real-World Evidence Suggests Differential Outcomes Between Abiraterone and Darolutamide in Hormone-Sensitive Prostate Cancer
/in Retrospective studies/by MaxDarolutamide Linked to Cognitive Benefit Over Enzalutamide in Prostate Cancer
/in Clinical Trial, Metastatic, Non-Metastatic, Phase 2, Phase 2/by MaxCT‑Measured Muscle Quality Predicts Survival in Men with Non‑Metastatic Castration‑Resistant Prostate Cancer
/in Retrospective studies/by Max